Characterisation and internalisation of recombinant humanised HMFG-1 antibodies against MUC1

The humanised HMFG-1 immunoglobulin has been extensively developed as a clinical immunotherapeutic agent for MUC1 expressing tumours. We have constructed a single-chain Fv (scFv) and Fab fragment from this antibody and shown that both these species retain their specificity for MUC1. The scFv was les...

Descripción completa

Detalles Bibliográficos
Autores principales: Pericleous, L M, Richards, J, Epenetos, A A, Courtenay-Luck, N, Deonarain, M P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2005
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3216111/
https://www.ncbi.nlm.nih.gov/pubmed/16265351
http://dx.doi.org/10.1038/sj.bjc.6602847

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3216111/
https://www.ncbi.nlm.nih.gov/pubmed/16265351
http://dx.doi.org/10.1038/sj.bjc.6602847

Ejemplares similares